FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 332:677-678 March 9, 1995 Number 10 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Until recently, our understanding of the role of hemostatic factors in coronary artery disease was based primarily on cross-sectional studies, epidemiologic observations, and cross-cultural comparisons. In the past several years, however, the information derived from prospective epidemiologic studies has expanded considerably. Simultaneously, cell and molecular biologic studies have revealed some of the mechanisms that regulate the plasma levels and biologic activity of hemostatic proteins.

The first two reports from the Northwick Park Heart Study, published in 1980 and 1986,^1,2 demonstrated strong, independent associations of base-line plasma fibrinogen concentrations and factor VII coagulant activity with the risk of subsequent coronary events . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Yano, Y., Kitagawa, N., Gabazza, E. C., Morioka, K., Urakawa, H., Tanaka, T., Katsuki, A., Araki-Sasaki, R., Hori, Y., Nakatani, K., Taguchi, O., Sumida, Y., Adachi, Y. (2003). Increased Plasma Thrombin-Activatable Fibrinolysis Inhibitor Levels in Normotensive Type 2 Diabetic Patients with Microalbuminuria. J. Clin. Endocrinol. Metab. 88: 736-741 [Abstract] [Full Text]  
• Hori, Y., Gabazza, E. C., Yano, Y., Katsuki, A., Suzuki, K., Adachi, Y., Sumida, Y. (2002). Insulin Resistance Is Associated with Increased Circulating Level of Thrombin-Activatable Fibrinolysis Inhibitor in Type 2 Diabetic Patients. J. Clin. Endocrinol. Metab. 87: 660-665 [Abstract] [Full Text]  
• Fernandez, P., Marco, P., Marin, F., Roldan, V., Sogorb, F. (2002). The role of tissue plasminogen activator on the progression of the coronary disease. Eur Heart J 23: 88-88 [Full Text]  
• Mauriello, A., Sangiorgi, G., Palmieri, G., Virmani, R., Holmes, D. R. Jr, Schwartz, R. S., Pistolese, R., Ippoliti, A., Spagnoli, L. G. (2000). Hyperfibrinogenemia Is Associated With Specific Histocytological Composition and Complications of Atherosclerotic Carotid Plaques in Patients Affected by Transient Ischemic Attacks. Circulation 101: 744-750 [Abstract] [Full Text]  
• Huikuri, H. V., Jokinen, V., Syvanne, M., Nieminen, M. S., Airaksinen, K. E. J., Ikaheimo, M. J., Koistinen, J. M., Kauma, H., Kesaniemi, A. Y., Majahalme, S., Niemela, K. O., Frick, M. H. (1999). Heart Rate Variability and Progression of Coronary Atherosclerosis. Arterioscler. Thromb. Vasc. Bio. 19: 1979-1985 [Abstract] [Full Text]  
• Eto, K., Isshiki, T., Yamamoto, H., Takeshita, S., Ochiai, M., Yokoyama, N., Yoshimoto, R., Ikeda, Y., Sato, T. (1999). AJvW-2, an Anti-vWF Monoclonal Antibody, Inhibits Enhanced Platelet Aggregation Induced by High Shear Stress in Platelet-Rich Plasma From Patients With Acute Coronary Syndromes. Arterioscler. Thromb. Vasc. Bio. 19: 877-882 [Abstract] [Full Text]  
• Wamala, S. P., Murray, M. A., Horsten, M., Eriksson, M., Schenck-Gustafsson, K., Hamsten, A., Silveira, A., Orth-Gomer, K. (1999). Socioeconomic Status and Determinants of Hemostatic Function in Healthy Women. Arterioscler. Thromb. Vasc. Bio. 19: 485-492 [Abstract] [Full Text]  
• Geppert, A., Graf, S., Beckmann, R., Hornykewycz, S., Schuster, E., Binder, B. R., Huber, K. (1998). Concentration of Endogenous tPA Antigen in Coronary Artery Disease : Relation to Thrombotic Events, Aspirin Treatment, Hyperlipidemia, and Multivessel Disease. Arterioscler. Thromb. Vasc. Bio. 18: 1634-1642 [Abstract] [Full Text]  
• Margaglione, M., Cappucci, G., Colaizzo, D., Giuliani, N., Vecchione, G., Grandone, E., Pennelli, O., Di Minno, G. (1998). The PAI-1 Gene Locus 4G/5G Polymorphism Is Associated With a Family History of Coronary Artery Disease. Arterioscler. Thromb. Vasc. Bio. 18: 152-156 [Abstract] [Full Text]  
• Jansson, J.-H., Boman, K., Brannstrom, M., Nilsson, T. K. (1997). High Concentration of Thrombomodulin in Plasma Is Associated With Hemorrhage : A Prospective Study in Patients Receiving Long-term Anticoagulant Treatment. Circulation 96: 2938-2943 [Abstract] [Full Text]  
• Fernhall, B., Szymanski, L. M., Gorman, P. A., Milani, J., Paup, D. C., Kessler, C. M. (1997). Fibrinolytic Activity Is Similar in Physically Active Men With and Without a History of Myocardial Infarction. Arterioscler. Thromb. Vasc. Bio. 17: 1106-1113 [Abstract] [Full Text]  
• Burg, P. J. M. V. D., Hospers, J. E. H., Van Vliet, M., Mosterd, W. L., Bouma, B. N., Huisveld, I. A. (1997). Effect of endurance training and seasonal fluctuation on coagulation and fibrinolysis in young sedentary men. J. Appl. Physiol. 82: 613-620 [Abstract] [Full Text]  
• Svendsen, O. L., Hassager, C., Christiansen, C., Nielsen, J. D., Winther, K. (1996). Plasminogen Activator Inhibitor–1, Tissue-Type Plasminogen Activator, and Fibrinogen : Effect of Dieting With or Without Exercise in Overweight Postmenopausal Women. Arterioscler. Thromb. Vasc. Bio. 16: 381-385 [Abstract] [Full Text]  
• Otto, C., Richter, W. O., Ridker, P. M., Vaughan, D. E., van de Loo, J. C.W., Haverkate, F., Thompson, S. G. (1995). Hemostatic Factors and the Risk of Myocardial Infarction. NEJM 333: 389-390 [Full Text]